Literature DB >> 29769889

Making progress to stop tuberculosis.

G Taylor1.   

Abstract

Entities:  

Year:  2014        PMID: 29769889      PMCID: PMC5864470          DOI: 10.14745/ccdr.v40i06a01

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN: 1188-4169


× No keyword cloud information.
  6 in total

1.  A population-based study of tuberculosis epidemiology and innovative service delivery in Canada.

Authors:  M Jensen; A Lau; D Langlois-Klassen; J Boffa; J Manfreda; R Long
Journal:  Int J Tuberc Lung Dis       Date:  2012-01       Impact factor: 2.373

Review 2.  Adherence to tuberculosis care in Canadian Aboriginal populations, Part 2: a comprehensive approach to fostering adherent behaviour.

Authors:  Pamela Orr
Journal:  Int J Circumpolar Health       Date:  2011-04-21       Impact factor: 1.228

3.  Highlights of the new 7th edition of the Canadian Tuberculosis Standards.

Authors:  M Gale-Rowe; D Menzies; J Sutherland; T Wong
Journal:  Can Commun Dis Rep       Date:  2014-03-20

4.  Summary of the Public Health Network's Guidance for Tuberculosis Prevention and Control Programs in Canada.

Authors:  L Lord
Journal:  Can Commun Dis Rep       Date:  2014-03-20

5.  Tuberculosis in Canada: 1924-2012.

Authors:  V Gallant; S Ogunnaike-Cooke; M McGuire
Journal:  Can Commun Dis Rep       Date:  2014-03-20

6.  Modern contact investigation methods for enhancing tuberculosis control in aboriginal communities.

Authors:  Victoria J Cook; Lena Shah; Jennifer Gardy
Journal:  Int J Circumpolar Health       Date:  2012-05-25       Impact factor: 1.228

  6 in total
  2 in total

1.  Associated risk factor of tuberculosis infection among adult patients in Gedeo Zone, Southern Ethiopia.

Authors:  Kuma Diriba; Ephrem Awulachew
Journal:  SAGE Open Med       Date:  2022-03-25

2.  The prevalence of Mycobacterium tuberculosis using Gene Xpert among tuberculosis suspected patients in Gedeo Zone, Southern Ethiopia.

Authors:  Kuma Diriba; Gemechu Churiso
Journal:  Eur J Med Res       Date:  2022-02-12       Impact factor: 2.175

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.